Compugen | CGEN - Ebit





Ebit Veränderung Datum
Arca Biopharma USD -36.43M 2M 2026-03
aTyr Pharma USD -94.72K 26.75K 2026-06
Bio Path USD -297K 191K 2026-03
Brainstorm Cell Therapeutics USD -2.05M 1000 2026-03
Cara Therapeutics USD -7.05M 1.11M 2026-03
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -8.84M 180K 2026-06
Immunic USD -23.33M 2.67M 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
RedHill Biopharma USD 2.69M 47.97M 2023-06
TherapeuticsMD USD -1.77M 699K 2023-09